Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2018

Every FDA drug recall initiated in 2018, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,681 recalls, newest first.

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 2018 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class II · Moderate risk

Vitamin D3 Injection

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1087-2018
Class II · Moderate risk

Dehydrated Alcohol Solution

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1086-2018
Class II · Moderate risk

Morphine Sulf inhalation

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1085-2018
Class II · Moderate risk

DMSO 6.25% Opth Sol

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1081-2018
Class II · Moderate risk

Atropine 0.01% Opth Solution

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1080-2018
Class II · Moderate risk

10 mg/mL Rocuronium Bromide

CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

Terminated cGMP deviation PharMEDium Services, LLC D-1045-2018
Class II · Moderate risk

5 mg/mL Ephedrine Sulfate

CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

Terminated cGMP deviation PharMEDium Services, LLC D-1044-2018
Class II · Moderate risk

10 mcg/mL Fentanyl Citrate

CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

Terminated cGMP deviation PharMEDium Services, LLC D-1043-2018

Recalls by year